共 188 条
[1]
Smolen JS(2018)Rheumatoid arthritis Nat Rev Dis Primers 4 18001-656
[2]
Aletaha D(2018)Update on the prevalence and incidence of rheumatoid arthritis in Korea and an analysis of medical care and drug utilization Rheumatol Int 38 649-1755
[3]
Barton A(2018)Causes of death in rheumatoid arthritis: how do they compare to the general population? Arthritis Care Res 70 1748-690
[4]
Burmester GR(2019)Rheumatoid arthritis (RA) and cardiovascular disease Autoimmun Rev 18 679-28
[5]
Emery P(2017)EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update Ann Rheum Dis 76 17-1372
[6]
Firestein GS(2018)Diagnosis and management of rheumatoid arthritis: a review Jama 320 1360-127
[7]
Kavanaugh A(2015)Lipid profile changes in patients with chronic inflammatory arthritis treated with biologic agents and tofacitinib in randomized clinical trials: a systematic review and meta-analysis Arthritis Rheumatol 67 117-2311
[8]
McInnes IB(2019)Upadacitinib as monotherapy in patients with active rheumatoid arthritis and inadequate response to methotrexate (SELECT-MONOTHERAPY): a randomised, placebo-controlled, double-blind phase 3 study Lancet 393 2303-1438
[9]
Solomon DH(2013)Changes in lipoproteins associated with methotrexate or combination therapy in early rheumatoid arthritis: results from the treatment of early rheumatoid arthritis trial Arthritis Rheum 65 1430-466
[10]
Strand V(2015)Disease-modifying antirheumatic drug use and the risk of incident hyperlipidemia in patients with early rheumatoid arthritis: a retrospective cohort study Arthritis Care Res 67 457-477